- B2B
- Scale StageRapidly increasing operations
- Top InvestorsThis company has received a significant amount of investment from top investors
Variant Bio Funding
$105M
11 round
Variant Bio is active in the following markets / industries: biotechnology, pharmaceuticals and genetic testing. The company has secured funding across 1 rounds, totaling in an amount of $105M. Their most recent funding was raised on November 9, 2021.
Funding Rounds
B
$105000000